HINDUSTAN BIO SCIENCES LTD.HH

HINDUSTAN BIO SCIENCES LTD.

9.25INRD
+0.35+3.93%
As of today at 05:45 GMT
INR
No trades
See on Supercharts

HINDBIO fundamentals

Key facts

Market capitalization‪92.67 M‬INR
Founded2000
CEOVenkata Rama Mohan Jampana
About

Hindustan Bio Sciences Ltd. engages in the trade of pharmaceuticals and medical goods. Its product portfolio includes liquid injectables; liquid and dry syrups; eye, ear and nasal drops; pre-filled syringes; and non-sterile and sterile ointments; tablets; and capsules. The company was founded in 2000 and is headquartered in Hyderabad, India.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪92.67 M‬‬
Price to earning ratio (P/E)
90.04x
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
90.04x
Price to sales ratio (P/S)
Valuation ratios
‪0.00‬
‪3.50‬
‪7.00‬
‪10.50‬
‪14.00‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪90.00‬
‪180.00‬
‪270.00‬
‪360.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪10%‬
‪15%‬
‪20%‬
‪25%‬
‪30%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−1.50 M‬‬
‪0.00‬
‪‪1.50 M‬‬
‪‪3.00 M‬‬
‪‪4.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪1.00 M‬‬
‪‪2.00 M‬‬
‪‪3.00 M‬‬
‪‪4.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪1.00 M‬‬
‪‪2.00 M‬‬
‪‪3.00 M‬‬
‪‪4.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Pharmaceuticals
By country
Period: 2024
India

Dividends

Dividend yield, history and sustainability

No dividends
HINDBIO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪7.00 M‬‬
‪‪14.00 M‬‬
‪‪21.00 M‬‬
‪‪28.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪7.00 M‬‬
‪‪14.00 M‬‬
‪‪21.00 M‬‬
‪‪28.00 M‬‬
Assets
Liabilities